Nitric Oxide for preterm infants
Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator that has demonstrated its efficacy when used to treat severe hypoxemic respiratory failure associated to pulmonary hypertension in term or near term newborns since 1992. Premature newborn infants are not included in the approved indicat...
Saved in:
Main Authors: | Manuel Sánchez Luna (Author), Maria Luisa Franco (Author), Elena Zamora (Author), Belén Bernardo (Author) |
---|---|
Format: | Book |
Published: |
Hygeia Press di Corridori Marinella,
2013-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Postnatal longitudinal analysis of serum nitric oxide and eosinophil counts in extremely preterm infants
by: Hirokazu Watanabe, et al.
Published: (2024) -
Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome - cases presentation
by: Mihaela Demetrian, et al.
Published: (2020) -
Effectiveness of Synchronized Noninvasive Ventilation to Prevent Intubation in Preterm Infants
by: Cristina Ramos-Navarro, et al.
Published: (2016) -
Inhaled Nitric Oxide in preterm infants: a systematic review and individual patient data meta-analysis
by: Schreiber Michael D, et al.
Published: (2010) -
Nitric Oxide/Nitric Oxide Synthase System in the Pathogenesis of Neurodegenerative Disorders-An Overview
by: Olga-Maria Iova, et al.
Published: (2023)